Providing clinical confidence in reliable assessment of ovarian reserve and prediction of response to controlled ovarian stimulation
Mean female age at first birth has increased steadily over the past few decades in many developed countries. This postponement leads to couples attempting to have children during a period where female fertility is already in decline.
AMH is a direct serum marker of functional ovarian reserve and plays an important role in assessing ovarian reserve levels and therefore the capacity to provide eggs for fertilization.1,2
Serum AMH levels have been shown to remain relatively stable during the menstrual cycle and may be measured on any day of the cycle.1,2
AMH is a reliable marker for prediction of response to controlled ovarian stimulation and can therefore add prognostic information to the counseling and planning process for infertile couples seeking treatment.3